View more on these topics

iShares – iBloomberg European Pharmaceuticals

Friday, 30th March 2001.



Type: Exchange traded fund.

Aim: Growth linked to the Bloomberg European investable pharmaceuticals index.

Minimum investment: Subject to negotiation with stockbroker.

Maximum investment: None.

Investment split: 100 per cent linked to the Bloomberg European investable pharmaceuticals index.

Place of registration: Ireland.

Isa link: Yes.

Pep transfers: Yes.

Charges: Annual 0.5 per cent.

Commission: None.

Tel: 0845 3577000.

 

Recommended

Window to the web

Fax machines did not really take off as a method of business communication until the mid-1980s. When they did, within just a couple of years, the appearance of a fax number on a company&#39s letterhead changed from being exceptional to something expected of any efficient business.Today, it is equally important for businesses to show a […]

Diggle still has an IFA role at the Revenue

Former Treasury head of home financial services Paula Diggle will continue to exert significant influence over IFAs as she begins her new job at the Inland Revenue next week.Diggle was until recently the senior civil servant in charge of the industry at the Treasury and will now be deputy director savings and pension schemes policy […]

Permanent&#39s critical mortgage

Moving on to the main useful features and strong points of the plan, Rutter has a list: “Moving home option, although this is pretty standard in such plans, ability to reschedule over a longer term, 50 per cent children&#39s cover, no apparent upper limit on mortgage interest rate covered and high non-medical indemnity limits.”Moore also […]

Virginmoney.com gives stakeholder guidance

Financial services website Virginmoney.com is offering details of stakeholder providers and guidance on the new pension although the company is steering clear of the market.The site&#39s stakeholder wizard sits alongside similar guides for products sold by the company, including Isas, mortgages and personal loans. The interactive tool gives details on charges and fund choices to […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment